40995-61-7 Usage
Description
Ethyl 4,4-diethoxy-2-(ethoxymethylene)-3-oxobutyrate, commonly known as ethyl acetoacetate, is a colorless liquid with a fruity odor. It is a chemical compound derived from acetoacetic acid and features a β-keto group and two ethyl ester groups in its structure. This versatile precursor is widely used in the synthesis of various organic compounds, making it a valuable compound in the production of perfumes, essential oils, and other scented products.
Uses
Used in Flavoring and Fragrance Industry:
Ethyl 4,4-diethoxy-2-(ethoxymethylene)-3-oxobutyrate is used as a flavoring agent and fragrance in the food and cosmetic industries due to its pleasant aroma and fruity odor.
Used in Pharmaceutical Synthesis:
Ethyl 4,4-diethoxy-2-(ethoxymethylene)-3-oxobutyrate is used as an intermediate in the synthesis of various pharmaceuticals, contributing to the development of new medications.
Used in Agrochemical Production:
Ethyl 4,4-diethoxy-2-(ethoxymethylene)-3-oxobutyrate is used as an intermediate in the synthesis of agrochemicals, playing a role in the development of agricultural products.
Used in Dye Synthesis:
Ethyl 4,4-diethoxy-2-(ethoxymethylene)-3-oxobutyrate is used as an intermediate in the synthesis of dyes, contributing to the production of various colorants for different applications.
Check Digit Verification of cas no
The CAS Registry Mumber 40995-61-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,9,9 and 5 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 40995-61:
(7*4)+(6*0)+(5*9)+(4*9)+(3*5)+(2*6)+(1*1)=137
137 % 10 = 7
So 40995-61-7 is a valid CAS Registry Number.
InChI:InChI=1/C13H22O6/c1-5-16-9-10(12(15)17-6-2)11(14)13(18-7-3)19-8-4/h9,13H,5-8H2,1-4H3/b10-9-
40995-61-7Relevant articles and documents
Part 2: Structure-activity relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38α mitogen-activated protein kinase
Wurz, Ryan P.,Pettus, Liping H.,Henkle, Bradley,Sherman, Lisa,Plant, Matthew,Miner, Kent,McBride, Helen J.,Wong, Lu Min,Saris, Christiaan J.M.,Lee, Matthew R.,Chmait, Samer,Mohr, Christopher,Hsieh, Faye,Tasker, Andrew S.
scheme or table, p. 1680 - 1684 (2010/07/08)
A novel class of pyrazolopyridazine p38α mitogen-activated protein kinase (MAPK) inhibitors is disclosed. A structure activity relationship (SAR) investigation was conducted driven by the ability of these compounds to inhibit the p38α enzyme, the secretion of TNFα in a LPS-challenged THP1 cell line and TNFα-induced production of IL-8 in the presence of 50% human whole blood (hWB). This study resulted in the discovery of several inhibitors with IC50 values in the single-digit nanomolar range in hWB. Further investigation of the pharmacokinetic profiles of these lead compounds led to the identification of three potent and orally bioavailable p38α inhibitors 2h, 2m, and 13h. Inhibitor 2m was found to be highly selective for p38α/β over a panel of 402 other kinases in Ambit screening, and was highly efficacious in vivo in the inhibition of TNFα production in LPS-stimulated Lewis rats with an ED50 of ca. 0.08 mg/kg.